Consistent with our results, other studies have reported that FGF-1 significantly increases AMPK phosphorylation, preventing nonalcoholic fatty liver disease [47] and diabetic cardiomyopathy [45] in mice. Here, FGF1 is linked to diabetic cardiomyopathy.